Tradestie Institutional Equity Comparison Engine

CGCT vs IPOD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-06-05 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IPOD Overall Edge

IPOD Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to IPOD (IPOD) driven by superior Valuation while CGCT counters with relative strength in Momentum & Technical. Fundamentally, CGCT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IPOD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CGCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IPOD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IPOD
CGCT N/M vs IPOD N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner CGCT
1Y +18.9% vs +3.8% ยท 52W Pos 44% vs 100%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CGCT US Equity
CGCT
Institutional Equity
$11.90
-2.14% 1D
Market Cap $509.6M
1M Return +14.31%
1Y Return +18.88%
Forward P/E N/M
Unified AI Score
65.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0
IPOD US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
1M Return +0.97%
1Y Return +3.84%
Forward P/E N/M
Unified AI Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CGCT +18.88% IPOD +3.84% Spread: +4.61 pp (CGCT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CGCT TTM Op. Margin: 0.0% IPOD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGCT vs IPOD. Trailing 12-month operating profitability (CGCT 0.0% vs IPOD 0.0%) and valuation multiples (CGCT N/M vs IPOD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CGCT (2) vs IPOD (3)
Institutional Metric CGCT IPOD Criterion Row Winner
Market Capitalization Scale $509.6M $210.0M Larger Scale CGCT
Trailing P/E Ratio Valuation 41.0x 39.9x Lower Multiple IPOD
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% 0.0% Higher ROE Tie
52-Week Range Position Momentum 44% ($9โ€“$15) 100% ($10โ€“$10) Stronger Trend IPOD
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 85% Vol 0.00ฮฒ ยท 2% Vol Lower Realized Risk IPOD
Unified Institutional Score Composite Signal 65.0 / 100 (BUY) 58.0 / 100 (HOLD) Higher Composite CGCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CGCT vs IPOD Buy Guide
CGCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CGCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IPOD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IPOD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CGCT nor IPOD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.